EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer

Jinye Ding iD, Chunyan Wang, Yaoqi Sun, Jing Guo, Shupeng Liu iD, Zhongping Cheng

Biomolecules · 09.02.2023 · 13 (2) · 339

DOI: 10.3390/biom13020339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 09.02.2023. Verfasst von Jinye Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China. Hauptthemen laut MEDLINE: Genes, Regulator, Ovarian Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Shanghai Tenth People's Hospital Climbing talent program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ovarian cancer (OC) is one of the most malignant tumors in the female reproductive system, with a poor prognosis. Various responses to treatments including chemotherapy and immunotherapy are observed among patients due to their individual characteristics. Applicable prognostic markers could make it easier to refine risk stratification for OC patients. Autophagy is closely implicated in the occurrence and development of tumors, including OC. Whether autophagy -related genes can be used as prognostic markers for OC patients remains unclear.

Methods

The gene transcriptome data of 374 OC patients were downloaded from The Cancer Genome Atlas (TCGA) database. The correlation between the autophagy levels and outcomes of OC patients was identified through the single sample gene set enrichment analysis (ssGSEA). Recognized molecular markers of autophagy in different clinical specimens were detected by immunohistochemistry (IHC) assay. The gene set enrichment analysis (GSEA), ESTIMATE, and CIBERSORT analysis were applied to explore the correlation of autophagy with the tumor immune microenvironment (TIME). Single-cell RNA-sequencing (scRNA-seq) data from seven OC patients were included for characterizing cell-cell interaction patterns of autophagy-high or low tumor cells. Machine learning, Stepwise Cox regression and LASSO-Cox analysis were used to screen autophagy hub genes, which were used to establish an autophagy-related signature for prognosis evaluation. Four tumor immunotherapy cohorts were obtained from the GEO (Gene Expression Omnibus) database and the literature for autophagy risk score validation.

Results

The autophagy levels were closely related to the prognosis of the OC patients. Additionally, the autophagy levels were correlated with TIME status including immune score, and immune-cell infiltration. The scRNA-seq analysis found that tumor cells with high or low autophagy levels had different interactions with immune cells, especially macrophages. Eight autophagy-hub genes (ZFYVE1, AMBRA1, LAMP2, TRAF6, PDPK1, ATG2B, DAPK1 and TP53INP2) were screened for an autophagy-related signature. According to this signature, higher risk score was correlated with poor prognosis and better immunotherapy response in the OC patients.

Conclusions

The autophagy-related signature is applicable to predict the prognosis and immune checkpoint inhibitors (ICIs) therapy efficiency in OC patients. It is possible to identify OC patients who will respond to ICIs therapy and have a favorable prognosis, although more verification is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genes, RegulatorOvarian NeoplasmsHumansFemaleImmunotherapyAutophagyBiological AssayTumor MicroenvironmentNuclear ProteinsAdaptor Proteins, Signal TransducingAutophagy-Related ProteinsVesicular Transport Proteins3-Phosphoinositide-Dependent Protein Kinases

Stichwörter der Autor:innen

autophagyimmune microenvironmentimmunotherapyovarian cancerprognosis

Substanzen

TP53INP2 protein, humanNuclear ProteinsAMBRA1 protein, humanAdaptor Proteins, Signal TransducingATG2B protein, humanAutophagy-Related ProteinsVesicular Transport ProteinsPDPK1 protein, human3-Phosphoinositide-Dependent Protein Kinases

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
  • Institute of Gynecological Minimally Invasive Medicine, Tongji University School of Medicine, Shanghai 200072, China.

ORCID-Profile: Jinye Ding, Shupeng Liu

Förderung

  • Fundamental Research Funds for the Central Universities
  • Shanghai Tenth People's Hospital Climbing talent program
  • National Natural Science Foundation of China
  • Shanghai Tenth People’s Hospital

Zitieren

APA

Ding, J., Wang, C., Sun, Y., Guo, J., Liu, S., & Cheng, Z. (2023). Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer. Biomolecules, 13(2), 339. https://doi.org/10.3390/biom13020339

Vancouver

Ding J, Wang C, Sun Y, Guo J, Liu S, Cheng Z. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer. Biomolecules. 2023;13(2):339. doi:10.3390/biom13020339

BibTeX
@article{Ding2023,
  author = {Ding, Jinye and Wang, Chunyan and Sun, Yaoqi and Guo, Jing and Liu, Shupeng and Cheng, Zhongping},
  title = {Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {339},
  doi = {10.3390/biom13020339}
}
Kostenlos starten →